| Gene symbol | TNFSF9 | Synonyms | 4-1BB-L, CD137L, TNLG5A | Type of gene | protein-coding |
| Chromosome | 19 | Map location | 19p13.3 | dbXrefs | |
| Description | TNF superfamily member 9 | ||||
| GTO ID | GTC3998 |
| Trial ID | NCT03714334 |
| Disease | Brain Glioma |
| Altered gene | E1A|TNFSF9 |
| Therapeutic/Target gene | Therapeutic gene |
| Therapy | DNA oncolytic virus |
| Treatment | DNX-2440 |
| Phase | Phase1 |
| Recruitment status | Terminated |
| Title | Phase I Trial of DNX-2440 Oncolytic Adenovirus in Patients With Recurrent Glioblastoma |
| Year | 2018 |
| Country | Spain |
| Company sponsor | Clinica Universidad de Navarra, Universidad de Navarra |
| Other ID(s) | D2440GBM1 |
| Vector information | |||||||||||
|
|||||||||||
| Cohort 1 | |||||||
|
|||||||